A N Lieberman, M Kupersmith, E Estey, M Goldstein. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh： See more » Acetonitriles/administration & dosageAcetonitriles/therapeutic useAntiparkinson Agents/administration & dosageAntiparkinson Agents/therapeutic useDrug EvaluationErgolines/administration & dosageErgolines/therapeutic useHumansParkinson Disease/drug therapy
Substances： See more » AcetonitrilesAntiparkinson AgentsErgolines
Year: 1976 PMID： 74475 DOI： 10.1016/s0140-6736(76)90805-9
Source DB: PubMed Journal: Lancet ISSN： 0140-6736 Impact factor: 79.321